Somavert Subcutaneous Injection 10mg, manufactured by Pfizer, contains Pegvisomant (genetical recombination) (YJ code: 2499409D1022, 10 mg/bottle). This medication is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone.
Somavert Subcutaneous Injection 10mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →